EXSIGHT VENTURES
ExSight Ventures is a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. The firm consists of 2 accomplished retinal surgeons and a team of investment professionals that have partnered to address the need for funding early-stage ophthalmic-focused companies. The firm seeks investments in biotechnology, medical devices, pharmaceuticals and software solutions in ophthalmology.
EXSIGHT VENTURES
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical Venture Capital
Founded:
2015-09-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Google Apps For Business Register.com DNS Weebly Hosting
Similar Organizations
Canna Holdings
Canna Holdings invests in products and services within the medical cannabis industry.
Core Clinical
Core Clinical is focuses on being the best medical imaging core laboratory in the industry.
Sanitas Ventures
SaSanitas Ventures is an invesment company that focuses on investing venture capital and private equity on eye care industries.
Spire Bioventures
SPIRE Bioventures is a global player in the digital health/medical device/biotech industry.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-01 | DTx Pharma | ExSight Ventures investment in Series B - DTx Pharma | 100 M USD |
| 2020-12-22 | ONL Therapeutics | ExSight Ventures investment in Series B - ONL Therapeutics | 46.9 M USD |
| 2020-06-02 | Re-Vana Therapeutics | ExSight Ventures investment in Seed Round - Re-Vana Therapeutics | 3.25 M USD |
| 2020-01-06 | DTx Pharma | ExSight Ventures investment in Series A - DTx Pharma | 10.6 M USD |
| 2019-07-16 | Trefoil Therapeutics | ExSight Ventures investment in Series A - Trefoil Therapeutics | 28 M USD |
| 2017-05-17 | ONL Therapeutics | ExSight Ventures investment in Series A - ONL Therapeutics | 4.25 M USD |
| 2017-05-01 | LensGen | ExSight Ventures investment in Series A - LensGen | 21 M USD |
| 2017-01-05 | Trefoil Therapeutics | ExSight Ventures investment in Series A - Trefoil Therapeutics | 5.2 M USD |
| 2015-11-12 | RetroSense Therapeutics | ExSight Ventures investment in Series B - RetroSense Therapeutics | 6 M USD |
More informations about "ExSight Ventures"
ExSight Ventures - Crunchbase Investor Profile
ExSight Ventures is a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions. The firm consists of 2 accomplished retinal surgeons and a team of investment …See details»
Meet The Team — ExSight Ventures
James is a co-founder and partner at ExSight Ventures where he has helped lead the firm’s investments in nine transformative ophthalmic companies. In addition to serving on the ExSight investment committee he helms the firm’s operations. …See details»
ExSight Ventures - LinkedIn
ExSight Ventures | 825 followers on LinkedIn. Investing to preserve and restore vision. | We are a venture capital firm specializing in early-stage impact investments in innovative ophthalmic ...See details»
Learn - ExSight Ventures
Our wide-ranging discussion touched on everything from the history and formation of ExSight, how we operate with two very busy vitreoretinal surgeons, our investment process, a pair of …See details»
ExSight Ventures investment portfolio - PitchBook
ExSight Ventures General Information Company Description. Founded in 2014, Exsight Ventures is a venture capital firm based in New York, New York. The firm prefers to invest in …See details»
ExSight Ventures - Investments, Portfolio & Company Exits
ExSight Ventures 's most notable exits include DTx Pharma and RetroSense Therapeutics. Which industries has this organization had the most exits in? Show . DTx Pharma DTx Pharma is a …See details»
ExSight Ventures - Overview, News & Similar companies - ZoomInfo
Jun 1, 2020 ExSight Ventures invests in early-stage companies with innovative and impactful ophthalmic diagnostic and treatment solutions. The firm consists of two accomplished retinal …See details»
ExSight Ventures - Contacts, Employees, Board Members
ExSight Ventures has 7 current employee profiles, including Partner Adam Benowitz. ExSight Ventures has 2 board members and advisors, including Randolph Cohen. Contacts. Edit …See details»
ExSight Ventures - Private Equity List
ExSight Ventures. Investor type. VC. Last fund created. 2014. AUM-Location. United States. $1-5 m. Investment Ticket. 3-5 years. Investment Horizon. Seed Investment Stage. Sale to strategic …See details»
James C. Murray | Ophthalmology Innovation Source
James is a co-founder and partner at ExSight Ventures where he has helped lead the firm’s investments in nine transformative ophthalmic companies. In addition to serving on the ExSight investment committee he helms the firm’s operations. …See details»
2023 Year in Review — ExSight Ventures
Feb 8, 2024 ExSight Ventures is thrilled to share a few of our 2023 highlights: DTx Pharma’s FALCON™ soared to a Novartis acquisition: DTx Pharma, an ExSight portfolio company, …See details»
Horizon Surgical Systems Raises $30 Million in Series A Financing
Oct 16, 2024 ExSight Ventures Leads Financing Round to Support the Development of the Polaris System to Advance Eye Surgery. Horizon Surgical Systems, Inc., a privately-held, …See details»
Two Remaining Defendants of $1.3 Billion Investment Fraud (Ponzi ...
On July 12, 2021, Los Angeles County, California natives, Dane Roseman, 38, and Ivan Acevedo, 44, pled guilty to participating in a massive investment fraud scheme, in which more than …See details»
Partner & Co-Founder @ ExSight Ventures - Crunchbase
James is a co-founder and partner at ExSight Ventures where he has helped lead the firm’s investments in nine transformative ophthalmic companies. In addition to serving on the …See details»
Certified Companies - dvsv3.com
Mar 3, 2014 Certified Companies. The V3 community is represented by a wide range of industries across the Commonwealth, from large and small businesses alike.See details»
INTRODUCING THE EXSIGHT VENTURES SYNDICATE ON ANGELLIST
Oct 16, 2019 The ExSight Ventures Syndicate will provide our existing investors and other accredited investors access to the types of investments that comprise our current portfolio. …See details»
Competitive Power Ventures - Home
Competitive Power Ventures is a leading North American electric power generation development and asset management company headquartered in Silver Spring, Maryland, with offices in …See details»
Portfolio — ExSight Ventures
Qura receives strategic investment from Santen Ventures. Envision Diagnostics, Inc. Revolutionizing the eye exam. News: Envision Diagnostics raises Series A Financing. …See details»
Nearly 40,000 Northern Virginia businesses received PPP loans
Jul 10, 2020 Nearly 7,000 Northern Virginia companies and nonprofits have received Payroll Protection Plan loans of at least $150,000 apiece from the Small Business Administration, and …See details»